Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
10.1038/nature10154
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Sievers, S. A., Karanicolas, J., Chang, H. W., Zhao, A., Jiang, L., Zirafi, O., Stevens, J. T., Münch, J., Baker, D., & Eisenberg, D. (2011). Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature, 475(7354), 96–100.

Authors 10
  1. Stuart A. Sievers (first)
  2. John Karanicolas (additional)
  3. Howard W. Chang (additional)
  4. Anni Zhao (additional)
  5. Lin Jiang (additional)
  6. Onofrio Zirafi (additional)
  7. Jason T. Stevens (additional)
  8. Jan Münch (additional)
  9. David Baker (additional)
  10. David Eisenberg (additional)
References 49 Referenced 413
  1. Westermark, P. et al. A primer of amyloid nomenclature. Amyloid 14, 179–183 (2007) (10.1080/13506120701460923) / Amyloid by P Westermark (2007)
  2. Maji, S. K. et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328–332 (2009) (10.1126/science.1173155) / Science by SK Maji (2009)
  3. Fowler, D. M., Koulov, A. V., Balch, W. E. & Kelly, J. W. Functional amyloid – from bacteria to humans. Trends Biochem. Sci. 32, 217–224 (2007) (10.1016/j.tibs.2007.03.003) / Trends Biochem. Sci. by DM Fowler (2007)
  4. Astbury, W. T. & Dickinson, S. The X-ray interpretation of denaturation and the structure of the seed globulins. Biochem. J. 29, 2351–2360 (1935) (10.1042/bj0292351) / Biochem. J. by WT Astbury (1935)
  5. Calamai, M., Chiti, F. & Dobson, C. M. Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys. J. 89, 4201–4210 (2005) (10.1529/biophysj.105.068726) / Biophys. J. by M Calamai (2005)
  6. Tjernberg, L. O. et al. Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271, 8545–8548 (1996) (10.1074/jbc.271.15.8545) / J. Biol. Chem. by LO Tjernberg (1996)
  7. Findeis, M. A. Peptide inhibitors of β amyloid aggregation. Curr. Top. Med. Chem. 2, 417–423 (2002) (10.2174/1568026024607508) / Curr. Top. Med. Chem. by MA Findeis (2002)
  8. Sciarretta, K. L., Gordon, D. J. & Meredith, S. C. Peptide-based inhibitors of amyloid assembly. Methods Enzymol. 413, 273–312 (2006) (10.1016/S0076-6879(06)13015-3) / Methods Enzymol. by KL Sciarretta (2006)
  9. Soto, C., Kindy, M. S., Baumann, M. & Frangione, B. Inhibition of Alzheimer’s amyloidosis by peptides that prevent β-sheet conformation. Biochem. Biophys. Res. Commun. 226, 672–680 (1996) (10.1006/bbrc.1996.1413) / Biochem. Biophys. Res. Commun. by C Soto (1996)
  10. Kokkoni, N., Stott, K., Amijee, H., Mason, J. M. & Doig, A. J. N-methylated peptide inhibitors of amyloid aggregation and toxicity. Optimization of the inhibitor structure. Biochemistry 45, 9906–9918 (2006) (10.1021/bi060837s) / Biochemistry by N Kokkoni (2006)
  11. Sato, T. et al. Inhibitors of amyloid toxicity based on β-sheet packing of Aβ40 and Aβ42. Biochemistry 45, 5503–5516 (2006) (10.1021/bi052485f) / Biochemistry by T Sato (2006)
  12. Larbig, G., Pickhardt, M., Lloyd, D. G., Schmidt, B. & Mandelkow, E. Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hopping. Curr. Alzheimer Res. 4, 315–323 (2007) (10.2174/156720507781077250) / Curr. Alzheimer Res. by G Larbig (2007)
  13. Wiesehan, K. et al. Selection of D-amino-acid peptides that bind to Alzheimer’s disease amyloid peptide aβ1–42 by mirror image phage display. ChemBioChem 4, 748–753 (2003) (10.1002/cbic.200300631) / ChemBioChem by K Wiesehan (2003)
  14. Nelson, R. et al. Structure of the cross-β spine of amyloid-like fibrils. Nature 435, 773–778 (2005) (10.1038/nature03680) / Nature by R Nelson (2005)
  15. Sawaya, M. R. et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 447, 453–457 (2007) (10.1038/nature05695) / Nature by MR Sawaya (2007)
  16. Wiltzius, J. J. et al. Molecular mechanisms for protein-encoded inheritance. Nature Struct. Mol. Biol. 16, 973–978 (2009) (10.1038/nsmb.1643) / Nature Struct. Mol. Biol. by JJ Wiltzius (2009)
  17. Selkoe, D. J. Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81, 741–766 (2001) (10.1152/physrev.2001.81.2.741) / Physiol. Rev. by DJ Selkoe (2001)
  18. Goux, W. J. et al. The formation of straight and twisted filaments from short tau peptides. J. Biol. Chem. 279, 26868–26875 (2004) (10.1074/jbc.M402379200) / J. Biol. Chem. by WJ Goux (2004)
  19. von Bergen, M. et al. Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure. Proc. Natl Acad. Sci. USA 97, 5129–5134 (2000) (10.1073/pnas.97.10.5129) / Proc. Natl Acad. Sci. USA by M von Bergen (2000)
  20. Goldschmidt, L., Teng, P. K., Riek, R. & Eisenberg, D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl Acad. Sci. USA 107, 3487–3492 (2010) (10.1073/pnas.0915166107) / Proc. Natl Acad. Sci. USA by L Goldschmidt (2010)
  21. Thompson, M. J. et al. The 3D profile method for identifying fibril-forming segments of proteins. Proc. Natl Acad. Sci. USA 103, 4074–4078 (2006) (10.1073/pnas.0511295103) / Proc. Natl Acad. Sci. USA by MJ Thompson (2006)
  22. Münch, J. et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131, 1059–1071 (2007) (10.1016/j.cell.2007.10.014) / Cell by J Münch (2007)
  23. Friedhoff, P., von Bergen, M., Mandelkow, E. M., Davies, P. & Mandelkow, E. A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc. Natl Acad. Sci. USA 95, 15712–15717 (1998) (10.1073/pnas.95.26.15712) / Proc. Natl Acad. Sci. USA by P Friedhoff (1998)
  24. Wille, H., Drewes, G., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro . J. Cell Biol. 118, 573–584 (1992) (10.1083/jcb.118.3.573) / J. Cell Biol. by H Wille (1992)
  25. Kuhlman, B. et al. Design of a novel globular protein fold with atomic-level accuracy. Science 302, 1364–1368 (2003) (10.1126/science.1089427) / Science by B Kuhlman (2003)
  26. Chen, Z., Krause, G. & Reif, B. Structure and orientation of peptide inhibitors bound to β-amyloid fibrils. J. Mol. Biol. 354, 760–776 (2005) (10.1016/j.jmb.2005.09.055) / J. Mol. Biol. by Z Chen (2005)
  27. Roan, N. R. et al. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J. Virol. 83, 73–80 (2009) (10.1128/JVI.01366-08) / J. Virol. by NR Roan (2009)
  28. Petrassi, H. M., Klabunde, T., Sacchettini, J. & Kelly, J. W. Structure-based design of N-phenyl phenoxazine transthyretin amyloid fibril inhibitors. J. Am. Chem. Soc. 122, 2178–2192 (2000) (10.1021/ja993309v) / J. Am. Chem. Soc. by HM Petrassi (2000)
  29. Schweers, O., Schonbrunn-Hanebeck, E., Marx, A. & Mandelkow, E. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for β-structure. J. Biol. Chem. 269, 24290–24297 (1994) (10.1016/S0021-9258(19)51080-8) / J. Biol. Chem. by O Schweers (1994)
  30. Fleishman, S. J. et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332, 816–821 (2011) (10.1126/science.1202617) / Science by SJ Fleishman (2011)
  31. Collaborative Computational Project, Number 4 . The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994)
  32. Lawrence, M. C. & Colman, P. M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234, 946–950 (1993) (10.1006/jmbi.1993.1648) / J. Mol. Biol. by MC Lawrence (1993)
  33. Studier, F. W., Rosenberg, A. H., Dunn, J. J. & Dubendorff, J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185, 60–89 (1990) (10.1016/0076-6879(90)85008-C) / Methods Enzymol. by FW Studier (1990)
  34. Biernat, J. et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11, 1593–1597 (1992) (10.1002/j.1460-2075.1992.tb05204.x) / EMBO J. by J Biernat (1992)
  35. Barghorn, S., Biernat, J. & Mandelkow, E. Purification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitro. Methods Mol. Biol. 299, 35–51 (2005) / Methods Mol. Biol. by S Barghorn (2005)
  36. Friedhoff, P., Schneider, A., Mandelkow, E. M. & Mandelkow, E. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 37, 10223–10230 (1998) (10.1021/bi980537d) / Biochemistry by P Friedhoff (1998)
  37. Pérez, M., Valpuesta, J. M., Medina, M., Montejo de Garcini, E. & Avila, J. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J. Neurochem. 67, 1183–1190 (1996) (10.1046/j.1471-4159.1996.67031183.x) / J. Neurochem. by M Pérez (1996)
  38. Schweers, O., Mandelkow, E. M., Biernat, J. & Mandelkow, E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc. Natl Acad. Sci. USA 92, 8463–8467 (1995) (10.1073/pnas.92.18.8463) / Proc. Natl Acad. Sci. USA by O Schweers (1995)
  39. R Development Core Team . R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna) 〈 http://www.r-project.org 〉 (2008) / R: A Language and Environment for Statistical Computing by R Development Core Team (2008)
  40. Rojas Quijano, F. A., Morrow, D., Wise, B. M., Brancia, F. L. & Goux, W. J. Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides. Biochemistry 45, 4638–4652 (2006) (10.1021/bi052226q) / Biochemistry by FA Rojas Quijano (2006)
  41. Morris, A. M., Watzky, M. A., Agar, J. N. & Finke, R. G. Fitting neurological protein aggregation kinetic data via a 2-step, minimal “Ockham’s razor” model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth. Biochemistry 47, 2413–2427 (2008) (10.1021/bi701899y) / Biochemistry by AM Morris (2008)
  42. Schmidt, K., Segond von Banchet, G. & Heppelmann, B. Labelling of peptides with 1.4-nm gold particles to demonstrate their binding sites in the rat spinal cord. J. Neurosci. Methods 87, 195–200 (1999) (10.1016/S0165-0270(99)00003-5) / J. Neurosci. Methods by K Schmidt (1999)
  43. Eisenberg, D., Wesson, M. & Yamashita, M. Interpretation of protein folding and binding with atomic solvation parameters. Chem. Scr. 29A, 217–221 (1989) / Chem. Scr. by D Eisenberg (1989)
  44. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007) (10.1107/S0021889807021206) / J. Appl. Crystallogr. by AJ McCoy (2007)
  45. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240–255 (1997) (10.1107/S0907444996012255) / Acta Crystallogr. D by GN Murshudov (1997)
  46. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004) (10.1107/S0907444904019158) / Acta Crystallogr. D by P Emsley (2004)
  47. DeLano, W. L. PyMOL Molecular Viewer 〈 http://www.pymol.org 〉 (2002) / PyMOL Molecular Viewer by WL DeLano (2002)
  48. Papkalla, A., Munch, J., Otto, C. & Kirchhoff, F. Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism. J. Virol. 76, 8455–8459 (2002) (10.1128/JVI.76.16.8455-8459.2002) / J. Virol. by A Papkalla (2002)
  49. Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B. & Kabat, D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72, 2855–2864 (1998) (10.1128/JVI.72.4.2855-2864.1998) / J. Virol. by EJ Platt (1998)
Dates
Type When
Created 14 years, 2 months ago (June 14, 2011, 12:03 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 1:52 p.m.)
Indexed 1 week, 1 day ago (Aug. 28, 2025, 8:47 a.m.)
Issued 14 years, 2 months ago (June 15, 2011)
Published 14 years, 2 months ago (June 15, 2011)
Published Online 14 years, 2 months ago (June 15, 2011)
Published Print 14 years, 2 months ago (July 1, 2011)
Funders 0

None

@article{Sievers_2011, title={Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation}, volume={475}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature10154}, DOI={10.1038/nature10154}, number={7354}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Sievers, Stuart A. and Karanicolas, John and Chang, Howard W. and Zhao, Anni and Jiang, Lin and Zirafi, Onofrio and Stevens, Jason T. and Münch, Jan and Baker, David and Eisenberg, David}, year={2011}, month=jun, pages={96–100} }